Clinical Trial Update: Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027) [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting the safety and pharmacokinetics of single doses of MK-0941 in individuals with Type 2 diabetes; the study is completed and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• MK-0941

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2012-12-13